Cargando…
MiR-30c/PGC-1β protects against diabetic cardiomyopathy via PPARα
BACKGROUND: Metabolic abnormalities have been implicated as a causal event in diabetic cardiomyopathy (DCM). However, the mechanisms underlying cardiac metabolic disorder in DCM were not fully understood. RESULTS: Db/db mice, palmitate treated H9c2 cells and primary neonatal rat cardiomyocytes were...
Autores principales: | Yin, Zhongwei, Zhao, Yanru, He, Mengying, Li, Huaping, Fan, Jiahui, Nie, Xiang, Yan, Mengwen, Chen, Chen, Wang, Dao Wen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6329097/ https://www.ncbi.nlm.nih.gov/pubmed/30635067 http://dx.doi.org/10.1186/s12933-019-0811-7 |
Ejemplares similares
-
MiR-21 protected against diabetic cardiomyopathy induced diastolic dysfunction by targeting gelsolin
por: Dai, Beibei, et al.
Publicado: (2018) -
Mir30c Is Involved in Diabetic Cardiomyopathy through Regulation of Cardiac Autophagy via BECN1
por: Chen, Chen, et al.
Publicado: (2017) -
MiR-30c-5p ameliorates hepatic steatosis in leptin receptor-deficient (db/db) mice via down-regulating FASN
por: Fan, Jiahui, et al.
Publicado: (2017) -
MiR‐30c protects diabetic nephropathy by suppressing epithelial‐to‐mesenchymal transition in db/db mice
por: Zhao, Yanru, et al.
Publicado: (2017) -
miR-320a mediates doxorubicin-induced cardiotoxicity by targeting VEGF signal pathway
por: Yin, Zhongwei, et al.
Publicado: (2016)